6523
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

PHC Holdings Corporation is a holding company comprising three business domains: Diabetes Management, Healthcare Solutions, and Diagnostics & Life Science. The Diabetes Management domain develops, manufactures, and sells blood glucose monitoring systems and related consumables, primarily through subsidiaries PHC and Ascensia Diabetes Care Holdings AG, serving medical institutions and pharmacies globally. The Healthcare Solutions domain provides clinical testing services via LSI Medience, healthcare IT products such as electronic medical records and pharmacy systems through WeMacs, and contract research organization services including non-clinical trials and bioanalysis via Mediford. The Diagnostics & Life Science domain offers pathology equipment, biomedica devices like freezers and incubators, and point-of-care testing instruments, developed and sold by PHC and Epredia Holdings Ltd. subsidiaries. The group operates through a network of domestic and overseas subsidiaries, including PT PHC Indonesia for manufacturing and regional sales entities in North America, Europe, and Asia.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Devices Homepage phchd.com
Sector Healthcare IR page phchd.com/global
Tags
blood glucose monitoring, clinical testing, healthcare it, contract research organization, pathology equipment, biomedical refrigeration, point-of-care testing, bioanalysis, electronic medical records, pharmacy systems, PHC, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., LSI Medience, WeMacs, Mediford, PT PHC Indonesia, PHC Corporation of North America, PHC Europe B.V., PHC Shanghai Co. Ltd., SciMed (ASIA) Pte Ltd, PT PHC Sales Indonesia, Epredia Laboratory Products Manufacturing (Shanghai) Co. Ltd.
Press page phchd.com/jp/news

Metrics

Valuation  
Market cap ¥ 183.861B
Market cap (USD) $ 1.149B
P/E 12.75
PEG —
P/BV 1.09
P/S 0.50
P/OCF 3.57
P/FCF 4.35
Dividend yield 2.9%
Turnover / mcap —
Returns  
ROE 0.33%
ROI 0.12%
ROIC 2.9%
Profit margin 0.14%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 38
Quality score -22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 364.403B 361.593B 353.9B 356.434B 340.452B 306.071B 272.637B 186.546B 6.683B
Net profit 492M 10.485B -12.893B -3.222B -8.46B 16.906B 5.276B 15.453B 757M
Free cash flow 33.365B 30.331B 26.674B 9.86B 39.317B — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 1.089K 1.021K 1.236K 1.432K 1.808K — — — —
Price performance 12m 0.07 -0.17 -0.14 -0.21 — — — — —

Filed figures

Figure Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 63.5B 63.7B 69.3B 73.8B 70.5B 70.3B
↳ YoY growth +0.4% +8.7% +6.5% -4.4% -0.4%
↳ 5y CAGR +2.1%
Borrowings, current (JPY) 321B 27.3B 30.2B 36.9B 34.3B 78.3B
Borrowings, non-current (JPY) 67M 281B 262B 248B 221B 156B
Cash and deposits (JPY) 60.8B 95.2B 60.9B 47B 39.6B 39.8B
Intangible assets (JPY) 109B 99.1B 91.1B 91.4B 80.6B 74.4B
Right-of-use assets (JPY) 14.6B 13B 12.6B 12.8B 12.3B 15.1B
Net debt (borrowings + leases - cash) (JPY) 261B 213B 232B 238B 216B 195B
Cash flow detail
Operating cash flow (JPY) 47.9B 51.1B 21.4B 41.3B 41.9B 42.5B
Purchases of property, plant and equipment (JPY) -12.2B -11.7B -11.5B -14.6B -11.6B -9.09B
Change in receivables (cash effect) (JPY) -6.63B 107M -969M 3.06B 3.06B 3.99B
Change in inventories (cash effect) (JPY) -2.42B -3.82B -4.49B 4.37B -193M 2.23B
Change in payables (cash effect) (JPY) 4.77B -354M -7.42B -1.48B -2.6B 2.92B
Dividends paid (cash effect) (JPY) — — -9.2B -9.04B -4.92B -5.31B
Share buybacks (cash effect) (JPY) -588M -359M — — — —
Interest paid (cash effect) (JPY) -4.42B -3.01B -5.18B -5.94B -6.57B -5.33B
Income taxes paid (cash effect) (JPY) -3.69B -7.09B -15.4B -6.85B -3.98B -7.02B
Operating cash flow before change in receivables (JPY) 54.5B 50.9B 22.3B 38.2B 38.9B 38.5B
Free cash flow (OCF - PPE - intangibles) (JPY) 35.7B 39.3B 9.86B 26.7B 30.3B 33.4B
Income detail
Research and development expense (JPY) — 10.3B 9.93B 12B 10.7B 10.9B
Total comprehensive income (JPY) 26.2B 3.74B 11.2B 11.9B 6.28B 24.1B
Comprehensive income to owners (JPY) 26.2B 3.51B 10.9B 11.9B 6.4B 24.5B
Segments
Diabetes Management · Segment revenue (JPY) 108B 109B 112B 109B 98.7B 102B
↳ YoY growth +1.1% +2.2% -2.5% -9.5% +2.9%
Diabetes Management · Segment operating income (JPY) 23.9B 23.3B 26.7B 15.3B 13.9B 20.1B
Diagnostics And Life Sciences · Segment revenue (JPY) 79.9B 92.2B 109B 109B 131B 128B
↳ YoY growth +15.5% +17.9% +0.3% +20.1% -2.0%
Diagnostics And Life Sciences · Segment operating income (JPY) 508M -14.1B -1.07B 6.02B 7.25B 3.89B
Healthcare Solutions · Segment revenue (JPY) 116B 136B 134B 133B 128B 128B
↳ YoY growth +17.4% -2.0% -0.1% -3.8% +0.1%
Healthcare Solutions · Segment operating income (JPY) 4.51B 17B 9.83B -9.15B 9.27B 6.23B
Reported Jun 29, 2022 Jun 29, 2022 Jun 23, 2023 Jun 26, 2024 Jun 25, 2025 Jun 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

変更報告書(三菱ケミカル株式会社) Bull 0 Bear 0 Routine
変更報告書(三井物産株式会社) Bull 0 Bear 0 Routine

Prompts

PHC Holdings Corporation (ticker 6523), listed in Japan.

ETFs Holding PHC Holdings Corporation

ETF Weight in ETF Shares Market value As of
DISV 0.05% 289,400 $ 2.324M Nov 12, 2026
DFIS 0.01% 96,200 $ 772.488K Nov 12, 2026
AVDS 0.01% 3,600 $ 28.312K Nov 16, 2026
DXIV 0.01% 2,900 $ 23.287K Nov 12, 2026
DFIC 0.00% 75,100 $ 603.054K Nov 12, 2026
DFSI 0.00% 4,300 $ 34.529K Nov 12, 2026
DFAI 0.00% 47,404 $ 380.655K Nov 12, 2026
DFAX 0.00% 29,100 $ 233.674K Nov 12, 2026